Advanced visualization software developer Imaging Biometrics (IB) and brain imaging software developer CorTechs Labs have inked a nonexclusive business development agreement.
Under the deal, CorTechs will now market the firm's IB Neuro and IB Delta Suite applications in the U.S. and international markets. In addition, CorTechs will also represent the company's IB StoneChecker kidney stone analysis software internationally. StoneChecker is currently pending clearance by the U.S. Food and Drug Administration (FDA), IB said.
